InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

28
Insider
Date
Role
Action
Shares
Price
Amount
Theodore Alan Huizenga
15 Sep 2026
SVP, Chief Accounting Officer
Sold on a plan
1,283
$13.57
$17.41K
Howard Horn
3 Aug 2026
Chief Financial Officer
Sold on a plan
4,696
$24.92
$117.02K
Karah Herdman Parschauer
3 Aug 2026
EVP and Chief Legal Officer
Sold on a plan
1,900
$24.92
$47.35K
Howard Horn
1 Jul 2026
Chief Financial Officer
Sold on a plan
4,698
$33.13
$155.64K
Karah Herdman Parschauer
15 Jun 2026
EVP and Chief Legal Officer
Sold on a plan
1,899
$24.62
$46.75K
Howard Horn
1 Jun 2026
Chief Financial Officer
Sold on a plan
4,653
$23.77
$110.60K
Shehnaaz Suliman
18 May 2026
Director
Sold on a plan
5,740
$25.12
$144.19K
Howard Horn
1 May 2026
Chief Financial Officer
Sold on a plan
4,683
$24.90
$116.61K
Howard Horn
1 Apr 2026
Chief Financial Officer
Sold on a plan
4,683
$20.97
$98.20K
Howard Horn
3 Mar 2026
Chief Financial Officer
Sold on a plan
1,635
$22.40
$36.62K
Howard Horn
2 Mar 2026
Chief Financial Officer
Sold on a plan
3,119
$22.54
$70.30K
Howard Horn
2 Mar 2026
Chief Financial Officer
Sold on a plan
5,290
$22.80
$120.61K
Howard Horn
2 Feb 2026
Chief Financial Officer
Sold on a plan
3,061
$23.56
$72.12K
Howard Horn
2 Jan 2026
Chief Financial Officer
Sold on a plan
3,150
$22.84
$71.95K
Howard Horn
10 Dec 2025
Chief Financial Officer
Sold on a plan
3,081
$36.38
$112.09K
Corazon (Corsee) D. Sanders
20 Jun 2025
Director
Sold on a plan
2,405
$37.39
$89.92K
Emil D Kakkis
3 Mar 2025
President & CEO
Sold on a plan
73,434
$42.10
$3.09M
Emil D Kakkis
28 Feb 2025
President & CEO
Sold on a plan indirect
25,000
$42.48
$1.06M
Emil D Kakkis
30 Dec 2024
President & CEO
Sold on a plan indirect
11,727
$42.23
$495.23K
Emil D Kakkis
10 Dec 2024
President & CEO
Sold on a plan indirect
8,273
$50.00
$413.65K
Emil D Kakkis
3 Sep 2024
President & CEO
Sold on a plan indirect
20,000
$55.85
$1.12M
Emil D Kakkis
6 Aug 2024
President & CEO
Sold on a plan indirect
20,000
$50.17
$1.00M
Corazon (Corsee) D. Sanders
2 Jul 2024
Director
Sold on a plan
584
$40.98
$23.93K
Karah Herdman Parschauer
12 Jun 2024
EVP and Chief Legal Officer
Sold on a plan
9,806
$45.00
$441.27K
Corazon (Corsee) D. Sanders
10 Jun 2024
Director
Sold on a plan
1,737
$41.10
$71.39K
Matthew K Fust
7 Mar 2024
Director
Sold on a plan
7,500
$50.88
$381.60K
Matthew K Fust
7 Mar 2024
Director
Sold on a plan
2,145
$50.85
$109.07K
Matthew K Fust
7 Mar 2024
Director
Sold on a plan
2,550
$50.89
$129.77K
Show all 249 transactions →

What was left out

Form 4 filings counted 449
Amendments (4/A) skipped 11
Filings about a different issuer 3
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 28
Sales straight out of an exercise 57
Sales at will 149
Transactions with no price 0
Shares from compensation/vesting 3,103,818
Sales filed before the plan box existed 100
History held since 3 Feb 2014